{"status":"OK","data":{"advertisement":{"id":213028,"title":"\u201eUs\u0142uga polegaj\u0105ca na badaniu farmakokinetyki w celu oceny badanych artyku\u0142\u00f3w u myszy\u201d \n\u201cService to study pharmacokinetics to evaluate test articles in mice\u201d.","partial_offer_allowed":false,"publication_date":"2023-06-14","submission_deadline":"2023-07-14 23:59:59","planned_sign_date":"2023-07-01","supplementary_orders":null,"terms_of_contract_change":null,"created_at":"2023-06-14 15:42:46","modified_at":"2023-07-15 00:00:03","contact_persons":[{"id":3163,"forename":"Karolina","surname":"Miernik","phone_number":"","email":"k.miernik@purebiologics.com","created_by":null,"created_at":"2023-12-05 14:42:15","modified_at":"2023-12-05 14:42:15","modified_by":null}],"orders":[{"id":350926,"estimated_value":null,"order_items":[{"id":397098,"description":"Przedmiotem zam\u00f3wienia jest wykonanie us\u0142ugi badania farmakokinetyki w celu oceny badanych artyku\u0142\u00f3w u myszy, zgodnie z opisem badania znajduj\u0105cym si\u0119 w za\u0142\u0105czniku nr 2 do niniejszego zapytania ofertowego.\nPrzedmiot zam\u00f3wienia obejmuje r\u00f3wnie\u017c przygotowanie i dostarczenie Zamawiaj\u0105cemu raport\u00f3w z badania.\nZa\u0142\u0105cznik nr 2 zosta\u0142 sporz\u0105dzony w j\u0119zyku angielskim i za\u0142\u0105czony do niniejszego zapytania.\n\nThe subject of the order is service to study pharmacokinetics to evaluate test articles in mice as detailed in Attachment 2 to the inquiry no. PB004/06/2023. \nThe subject of the order also includes the preparation and delivery to the Ordering Party of reports on this study. \n","warranty_period":null,"cpv_items":[{"id":8513,"code":"73100000-3","name":"Us\u0142ugi badawcze i eksperymentalno-rozwojowe"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"dolno\u015bl\u0105skie","poviat":"Wroc\u0142aw","commune":"Wroc\u0142aw-Fabryczna","locality":"Wroc\u0142aw","created_by":null,"created_at":"2023-06-14 15:42:46","modified_at":"2023-06-14 15:42:53","modified_by":null,"id":447067,"type":{"id":1,"name":"adres"},"group_uuid":"6f669a70-3fcd-4d3d-9191-0766dc1ffede"}],"participation_conditions":[{"id":1084613,"description":"1.\tZamawiaj\u0105cy zastrzega, \u017ce oferty mog\u0105 z\u0142o\u017cy\u0107 wy\u0142\u0105cznie Oferenci, kt\u00f3rzy:\na)\tposiadaj\u0105 niezb\u0119dn\u0105 wiedz\u0119 i do\u015bwiadczenie, w tym udokumentowane do\u015bwiadczenie w badaniach farmakokinetycznych na myszach typu dzikiego - co najmniej 35 bada\u0144 przeprowadzonych w ci\u0105gu ostatnich 24 miesi\u0119cy; \nb)\tposiadaj\u0105 do\u015bwiadczenie, umiej\u0119tno\u015bci i zezwolenia etyczne do przeprowadzania bada\u0144 farmakokinetycznych;\nc)\tposiadaj\u0105 przeznaczone do bada\u0144 myszy o genotypach Balb/c lub CD-1, potwierdzone odpowiednimi certyfikatami;\nd)\twyznacz\u0105 g\u0142\u00f3wnego badacza projektu, kt\u00f3ry posiada co najmniej 5-letnie do\u015bwiadczenie w prowadzeniu bada\u0144 w dziedzinie farmakologii in vivo i farmakokinetyki;\ne)\tdysponuj\u0105 potencja\u0142em technicznym do wykonania zam\u00f3wienia, w tym: o\u015brodkiem dla zwierz\u0105t z potwierdzonym standardem SPF, zdolno\u015bci\u0105 do przeprowadzenia test\u00f3w na co najmniej 57 myszach jednocze\u015bnie, a tak\u017ce analiz\u0105 ELISA obejmuj\u0105c\u0105 wszystkie wymagane odczynniki;\nf)\tdysponuj\u0105 personelem wykwalifikowanym do realizacji umowy, w tym personelem uprawnionym do pracy ze zwierz\u0119tami, w tym eutanazji zwierz\u0105t oraz posiadaj\u0105cym udokumentowane do\u015bwiadczenie w pracy z myszami Balb/c lub CD-1 oraz metodami analitycznymi (w tym ELISA);\ng)\tzobowi\u0105zuj\u0105 si\u0119 do wykonania badania, zgodnie z warunkami i wymaganiami okre\u015blonymi w Za\u0142\u0105czniku nr 2, w terminie 6 tygodni od dnia podpisania umowy.\n\n1.\tThe Ordering Party reserves that tender may only be submitted by the Bidders who:\na)\thave the necessary knowledge and experience, including documented experience in pharmacokinetic studies in wild type mice - at least 35 studies conducted in the last 24 months; \nb)\thave experience, ability and ethical approvals to perform pharmacokinetic studies;\nc)\tdedicate mice with Balb/c or CD-1 genotypes for research, confirmed by appropriate certificates; \nd)\tdedicate a principal investigator to the project who has at least 5 years of experience in conducting research in the field of in vivo pharmacology and pharmacokinetics;\ne)\thave the technical potential to perform the contract, including: an animal facility with a confirmed SPF standard, the ability to conduct tests on at least 57 mice simultaneously as well as ELISA analysis inclusive all reagents required; \nf)\thave personnel qualified to perform the contract, including personnel authorized to work with animals, including euthanasia of animals, and with documented experience in working with Balb/c or CD-1 mice and analytical methods (inc. ELISA);\ng)\tundertake to perform, in accordance with the conditions and requirements set out in Attachment No. 2, within 6 weeks of signing the contract.","type":{"id":4,"name":"Osoby zdolne do wykonania zam\u00f3wienia"},"created_by":null,"created_at":"2023-06-14 15:42:46","modified_at":"2023-06-14 15:42:53","modified_by":null,"group_uuid":"80332551-765b-43ae-b7a6-2d5e7a2f2b1f"},{"id":1084614,"description":"Warunki oferty\n1.\tNie dopuszcza si\u0119 z\u0142o\u017cenia oferty cz\u0119\u015bciowej.\n2.\tNie dopuszcza si\u0119 z\u0142o\u017cenia oferty wariantowej.\n3.\tTermin zwi\u0105zania ofert\u0105 wynosi: 60 dni.\n\nConditions \n1.\tPartial bids are not allowed.\n2.\tSubmission of a variant offer is not allowed.\n3.\tThe validity period of the offer is: 60 days.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2023-06-14 15:42:46","modified_at":"2023-06-14 15:42:53","modified_by":null,"group_uuid":"71c00972-46b7-4f57-85f4-cff019e5a42d"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":8,"name":"Us\u0142ugi inne"},"created_by":null,"created_at":"2023-06-14 15:42:46","modified_at":"2023-06-14 15:42:53","modified_by":null,"group_uuid":"cb798de5-c4e5-42fd-9e12-de14b6d74b3f"}],"evaluation_criteria":[{"id":606948,"price_criterion":true,"description":"Cena 100%\nPrice 100%","created_by":null,"created_at":"2023-06-14 15:42:46","modified_at":"2023-06-14 15:42:53","modified_by":null,"group_uuid":"ef986b71-6972-40e3-b82f-7def267d0e40"}],"is_variant":false,"title":"Us\u0142uga/ Service","order_node":{"id":266941},"created_by":null,"created_at":"2023-06-14 15:42:46","modified_at":"2023-06-14 15:42:53","modified_by":null}],"created_by":{"id":95,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"Pure Biologics S.A.","identification_number_type":"nip","identification_number":"8943003192","address":{"country":"Polska","voivodeship":"dolno\u015bl\u0105skie","poviat":"Wroc\u0142aw","commune":"Wroc\u0142aw-Fabryczna","locality":"Wroc\u0142aw","created_by":null,"created_at":null,"modified_at":null,"modified_by":null,"id":556519,"street":"Du\u0144ska","number_description":"11","postcode":"54-427"},"created_by":{"id":95,"contact_persons":[]},"created_at":"2023-06-14 15:42:45","modified_at":"2023-06-14 15:42:45","modified_by":{"id":95,"contact_persons":[]},"id":213512},"advertisement":{"id":162511,"number":"2023-95-162511","publication_date":"2023-06-14","created_by":{"id":95,"contact_persons":[]},"created_at":"2023-06-14 15:42:45","modified_at":"2023-07-15 00:00:03","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[213028],"enrollment":null,"projects":[{"id":16222,"name":"Opracowanie bispecyficznego fragmentu przeciwcia\u0142a do symultanicznego zwalczania nowotworu i rekrutacji kom\u00f3rek uk\u0142adu immunologicznego (BIKE)","number":"0209/19","activity":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2020-08-17 19:00:00","modified_at":"2020-08-17 19:00:00","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"region":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2022-02-10 21:45:42","modified_at":"2022-02-10 21:45:42","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"institution":null,"full_number":"POIR.01.01.01-00-0209/19","perspective":{},"programme":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2020-08-17 19:00:00","modified_at":"2020-08-17 19:00:00","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"priority":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2020-08-17 19:00:00","modified_at":"2020-08-17 19:00:00","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"type":"project","created_by":{"id":95,"contact_persons":[]},"created_at":"2021-04-09 17:47:11","modified_at":"2021-04-09 17:47:11","modified_by":{"id":95,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":213028,"publication_date":"2023-06-14"},"id":1037497,"name":"PB004/06/2023- Zapytanie Ofertowe, Za\u0142. 1, Za\u0142.3","file":{"id":1156144,"name":"PB004_06_2023- Zapytanie Ofertowe, Za\u0142. 1, Za\u0142.3.pdf","created_at":"2023-06-14 15:39:50","created_by":{"forename":"Karolina","surname":"Miernik"},"uri":"/api/files/1156144"},"group_uuid":"d7640f1f-c083-4437-90a4-7707b4cf1aac"},{"origin":{"id":213028,"publication_date":"2023-06-14"},"id":1037498,"name":"PB004/06/2023-Request for tender and Att. 1,3","file":{"id":1156145,"name":"PB004_06_2023-Request for tender Att1 v2.pdf","created_at":"2023-06-14 15:40:12","created_by":{"forename":"Karolina","surname":"Miernik"},"uri":"/api/files/1156145"},"group_uuid":"75e40c44-8b33-414a-a095-7a11b880e402"},{"origin":{"id":213028,"publication_date":"2023-06-14"},"id":1037499,"name":"PB004/06/2023- Za\u0142\u0105cznik nr 1 i 3- wersje edytowalne","file":{"id":1156152,"name":"PB004_06_2023- Za\u0142\u0105cznik nr 1 i 3.docx","created_at":"2023-06-14 15:40:45","created_by":{"forename":"Karolina","surname":"Miernik"},"uri":"/api/files/1156152"},"group_uuid":"dbd8fa00-07d4-4675-aeac-0409e94b5f00"},{"origin":{"id":213028,"publication_date":"2023-06-14"},"id":1037500,"name":"PB004/06/2023-Attachments no. 1 and 3.- editable version","file":{"id":1156158,"name":"PB004_06_2023-Attachments no. 1 and 3.docx","created_at":"2023-06-14 15:41:55","created_by":{"forename":"Karolina","surname":"Miernik"},"uri":"/api/files/1156158"},"group_uuid":"009ac8a8-ea04-4c3b-b8ee-ddecdf577556"},{"origin":{"id":213028,"publication_date":"2023-06-14"},"id":1037501,"name":"PB004/06/2023 Attachment no.2","file":{"id":1156161,"name":"PB004_06_2023 Attachment no.2.pdf","created_at":"2023-06-14 15:42:29","created_by":{"forename":"Karolina","surname":"Miernik"},"uri":"/api/files/1156161"},"group_uuid":"2da02b77-1650-4674-a581-a5cb90f527cb"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}